ABVC Biopharma Inc (ABVC) stock forecast · rev $796.0K
ABVC Biopharma Inc (ABVC) is a biotechnology company listed on NASDAQ.
This ABVC forecast page states what the cached financials imply — not a price target and not a guarantee. ABVC Biopharma Inc outlooks on Lician start from reported revenue and the latest filing, then you decide.
Latest reported ABVC revenue for 2025-09-30 was $796.0K. Net income was -$1.3M. ABVC currently screens at market cap $35.9M.
Period-over-period revenue change is not in cache for ABVC, so this page does not invent a growth rate.
ABVC currently screens at market cap $35.9M. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.
When the next ABVC 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.
Not a prediction market. For the live quote and the full model, use the ABVC stock page.
Not investment advice.